Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease

Recruiting now

Conditions studied: Coronary Artery Disease

In brief

The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.

Key facts

Study ID

NCT05250557

Run by

Seoul National University Hospital

People needed

2429

Starts

2021-08-01

Expected to finish

2026-12-31

Last updated by the study team

2022-02-22

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥20 years
• All comers who underwent successful FFR measurement and pullback tracing

You may not qualify if…

• Chronic renal failure (estimated glomerular filtration rate <30)
• ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery history
• Primary myocardial or valvular disease
• Left ventricular ejection fraction < 30%
• Hemodynamically unstable clinical conditions
• Life expectancy < 2 years

Where it is running

• Seoul National University Hospital — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.